{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:26:19Z","timestamp":1777479979483,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1124\/jpet.121.000898","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T20:45:12Z","timestamp":1640292312000},"page":"180-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Andrographolide Analogue 3A.1 Synergizes with Taxane Derivatives in Aggressive Metastatic Prostate Cancers by Upregulation of Heat Shock Proteins and Downregulation of MAT2A-Mediated Cell Migration and Invasion"],"prefix":"10.1016","volume":"380","author":[{"given":"Taraswi","family":"Mitra Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teeratas","family":"Kansom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Alnaim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanese L.","family":"Jasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aedan","family":"Bird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praneet","family":"Opanasopit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit K.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000898_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4161\/cbt.12.5.15950","article-title":"Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer","volume":"12","author":"Aljuffali","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1124\/jpet.121.000898_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.59566\/IJBS.2009.5001","article-title":"Overview of major classes of plant-derived anticancer drugs","volume":"5","author":"Amin","year":"2009","journal-title":"Int J Biomed Sci"},{"key":"10.1124\/jpet.121.000898_bib3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/2159-8290.CD-17-0937","article-title":"Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer","volume":"8","author":"Annala","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1124\/jpet.121.000898_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/aja.aja_37_18","article-title":"Impact of taxanes on androgen receptor signaling","volume":"21","author":"Bai","year":"2019","journal-title":"Asian J Androl"},{"key":"10.1124\/jpet.121.000898_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.0956-5507.2003.00090.x","article-title":"Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value","volume":"15","author":"Bantis","year":"2004","journal-title":"Cytopathology"},{"key":"10.1124\/jpet.121.000898_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1124\/jpet.121.000898_bib7","first-page":"308","article-title":"Andrographolide, a novel NF-\u03baB inhibitor, inhibits vascular smooth muscle cell proliferation and cerebral endothelial cell inflammation","volume":"30","author":"Chang","year":"2014","journal-title":"Zhonghua Minguo Xinzangxue Hui Zazhi"},{"key":"10.1124\/jpet.121.000898_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1124\/jpet.121.000898_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semcdb.2003.09.021","article-title":"Heat shock proteins in mammalian development","volume":"14","author":"Christians","year":"2003","journal-title":"Semin Cell Dev Biol"},{"key":"10.1124\/jpet.121.000898_bib10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/1947601910383416","article-title":"Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth","volume":"1","author":"Chun","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1124\/jpet.121.000898_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.euf.2017.11.009","article-title":"Taxane-based combination therapies for metastatic prostate cancer","volume":"5","author":"Corn","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1124\/jpet.121.000898_bib12","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1080\/10408398.2018.1501657","article-title":"Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide","volume":"59","author":"Dai","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1124\/jpet.121.000898_bib13","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1158\/0008-5472.CAN-11-1417","article-title":"Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer","volume":"71","author":"Darshan","year":"2011","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.121.000898_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","volume":"376","author":"de Bono","year":"2010","journal-title":"Lancet"},{"key":"10.1124\/jpet.121.000898_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7915.2010.00221.x","article-title":"Natural products for cancer chemotherapy","volume":"4","author":"Demain","year":"2011","journal-title":"Microb Biotechnol"},{"key":"10.1124\/jpet.121.000898_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1158\/1535-7163.MCT-14-0155","article-title":"Mechanisms of resistance to cabazitaxel","volume":"14","author":"Duran","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.121.000898_bib17","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1038\/s41467-019-11594-y","article-title":"Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor","volume":"10","author":"Eftekharzadeh","year":"2019","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.121.000898_bib18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.18632\/oncotarget.26628","article-title":"Andrographolide induces DNA damage in prostate cancer cells","volume":"10","author":"Forestier-Rom\u00e1n","year":"2019","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.121.000898_bib19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41388-020-01598-0","article-title":"Loss and revival of androgen receptor signaling in advanced prostate cancer","volume":"40","author":"Formaggio","year":"2021","journal-title":"Oncogene"},{"key":"10.1124\/jpet.121.000898_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ctrv.2017.04.008","article-title":"Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer","volume":"57","author":"Galletti","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1124\/jpet.121.000898_bib21","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.3892\/ol.2017.6668","article-title":"Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens","volume":"14","author":"Glover","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1124\/jpet.121.000898_bib22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1158\/1541-7786.MCR-08-0325","article-title":"Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells","volume":"7","author":"Gueron","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1124\/jpet.121.000898_bib23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.juro.2011.04.070","article-title":"Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer","volume":"186","author":"Hall","year":"2011","journal-title":"J Urol"},{"key":"10.1124\/jpet.121.000898_bib24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.121.000898_bib25","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1208615","article-title":"The p53 pathway: positive and negative feedback loops","volume":"24","author":"Harris","year":"2005","journal-title":"Oncogene"},{"key":"10.1124\/jpet.121.000898_bib26","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2174\/0929867311320220001","article-title":"Targeting heat shock proteins in prostate cancer","volume":"20","author":"Hessenkemper","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.121.000898_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1758834012449685","article-title":"Overcoming docetaxel resistance in prostate cancer: a perspective review","volume":"4","author":"Hwang","year":"2012","journal-title":"Ther Adv Med Oncol"},{"key":"10.1124\/jpet.121.000898_bib28","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1208\/s12249-018-1139-4","article-title":"Apoptosis induction and antimigratory activity of andrographolide analog (3A.1)-incorporated self-assembled nanoparticles in cancer cells","volume":"19","author":"Kansom","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1124\/jpet.121.000898_bib29","article-title":"Fabrication and characterization of andrographolide analogue (3A.1) nanosuspensions stabilized by amphiphilic chitosan derivatives for colorectal cancer therapy","volume":"54","author":"Kansom","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1124\/jpet.121.000898_bib30","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.yexcr.2006.05.023","article-title":"CAIR-1\/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins","volume":"312","author":"Kassis","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1124\/jpet.121.000898_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1124\/jpet.121.000898_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7150\/jca.11038","article-title":"Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer","volume":"6","author":"Leite","year":"2015","journal-title":"J Cancer"},{"key":"10.1124\/jpet.121.000898_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1947601911409744","article-title":"Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer","volume":"2","author":"Liu","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1124\/jpet.121.000898_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075628","article-title":"MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth","volume":"8","author":"Lo","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.121.000898_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pros.20712","article-title":"Prostate-specific genes and their regulation by dihydrotestosterone [published correction appears in Prostate (2008) 68:1372]","volume":"68","author":"Ma","year":"2008","journal-title":"Prostate"},{"key":"10.1124\/jpet.121.000898_bib36","doi-asserted-by":"crossref","first-page":"16185","DOI":"10.18632\/oncotarget.24609","article-title":"Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines","volume":"9","author":"Machioka","year":"2018","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.121.000898_bib37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamaoncol.2015.2895","article-title":"Intermittent vs continuous androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis","volume":"1","author":"Magnan","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1124\/jpet.121.000898_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1535370217740860","article-title":"Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy","volume":"243","author":"Maldonado","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1124\/jpet.121.000898_bib39","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1158\/1078-0432.CCR-11-2527","article-title":"Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer","volume":"18","author":"Mang\u00e9","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.121.000898_bib73","doi-asserted-by":"crossref","first-page":"736951","DOI":"10.3389\/fphar.2021.736951","article-title":"Identification and characterization of key differentially expressed genes associated with metronomic dosing of topotecan in human prostate cancer","volume":"12","author":"Mitra Ghosh","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.121.000898_bib40","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1158\/1535-7163.MCT-16-0515","article-title":"fisetin enhances chemotherapeutic effect of cabazitaxel against human prostate cancer cells","volume":"15","author":"Mukhtar","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.121.000898_bib41","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.12688\/f1000research.15604.1","article-title":"Androgen-dependent alternative mRNA isoform expression in prostate cancer cells","volume":"7","author":"Munkley","year":"2018","journal-title":"F1000 Res"},{"key":"10.1124\/jpet.121.000898_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2013.12.002","article-title":"Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition","volume":"723","author":"Nateewattana","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000898_bib43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10637-012-9868-9","article-title":"Inhibition of topoisomerase II \u03b1 activity and induction of apoptosis in mammalian cells by semi-synthetic andrographolide analogues","volume":"31","author":"Nateewattana","year":"2013","journal-title":"Invest New Drugs"},{"key":"10.1124\/jpet.121.000898_bib44","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/sj.emboj.7600596","article-title":"TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death","volume":"24","author":"Ohoka","year":"2005","journal-title":"EMBO J"},{"key":"10.1124\/jpet.121.000898_bib45","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1200\/JCO.2016.72.1068","article-title":"Cabazitaxel versus docetaxel as first-line therapy for patients with metastatic castration-resistant prostate cancer: a randomized phase iii trial-FIRSTANA","volume":"35","author":"Oudard","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.121.000898_bib46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bcp.2010.11.006","article-title":"Synergistic antimicrotubule therapy for prostate cancer","volume":"81","author":"Pannu","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.121.000898_bib47","doi-asserted-by":"crossref","first-page":"69282","DOI":"10.1039\/C6RA12161F","article-title":"Strategies for formulation development of andrographolide","volume":"6","author":"Pawar","year":"2016","journal-title":"RSC Advances"},{"key":"10.1124\/jpet.121.000898_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115605","article-title":"Microarray-based identification of differentially expressed genes associated with andrographolide derivatives-induced resistance in colon and prostate cancer cell lines","volume":"425","author":"Quah","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.121.000898_bib49","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/annonc\/mdx348","article-title":"The evolution of chemotherapy for the treatment of prostate cancer","volume":"28","author":"Quinn","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1124\/jpet.121.000898_bib50","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.biopha.2018.02.119","article-title":"A silyl andrographolide analogue suppresses Wnt\/\u03b2-catenin signaling pathway in colon cancer","volume":"101","author":"Reabroi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1124\/jpet.121.000898_bib51","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/jpet.121.000898_bib52","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrm3658","article-title":"Chaperone machines for protein folding, unfolding and disaggregation","volume":"14","author":"Saibil","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.121.000898_bib53","first-page":"761","article-title":"Andrographolide induces degradation of mutant p53 via activation of Hsp70","volume":"53","author":"Sato","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.121.000898_bib54","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.121.000898_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139440","article-title":"Prevalence of prostate cancer clinical states and mortality in the United States: estimates using a dynamic progression model","volume":"10","author":"Scher","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.121.000898_bib56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/ijms19010263","article-title":"plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application","volume":"19","author":"Seca","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.121.000898_bib57","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2174\/1568026616666160413141911","article-title":"Heat shock protein (HSP) drug discovery and development: targeting heat shock proteins in disease","volume":"16","author":"Shrestha","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/jpet.121.000898_bib58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13277-010-0055-3","article-title":"BAG3 protein delocalisation in prostate carcinoma","volume":"31","author":"Staibano","year":"2010","journal-title":"Tumour Biol"},{"key":"10.1124\/jpet.121.000898_bib59","first-page":"262","article-title":"Expression of Ki-67 and PCNA as proliferating markers in prostate cancer","volume":"47","author":"Sulik","year":"2002","journal-title":"Rocz Akad Med Bialymst"},{"key":"10.1124\/jpet.121.000898_bib60","first-page":"148","article-title":"Neuroendocrine differentiation in prostate cancer","volume":"1","author":"Sun","year":"2009","journal-title":"Am J Transl Res"},{"key":"10.1124\/jpet.121.000898_bib61","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.12.033","article-title":"Words of wisdom. Re: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"65","author":"Tannock","year":"2014","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.121.000898_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/ecam\/nep135","article-title":"Andrographolide: a new plant-derived antineoplastic entity on horizon","volume":"2011","author":"Varma","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1124\/jpet.121.000898_bib63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1271\/bbb.90490","article-title":"Fangchinoline induced G1\/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft","volume":"74","author":"Wang","year":"2010","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1124\/jpet.121.000898_bib64","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jnutbio.2014.11.017","article-title":"Sensitization to docetaxel in prostate cancer cells by green tea and quercetin","volume":"26","author":"Wang","year":"2015","journal-title":"J Nutr Biochem"},{"key":"10.1124\/jpet.121.000898_bib65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5897\/AJMR10.383","article-title":"Andrographolide induces cell cycle arrest and apoptosis in PC-3 prostate cancer cells","volume":"5","author":"Wong","year":"2011","journal-title":"Afr J Pharm Pharmacol"},{"key":"10.1124\/jpet.121.000898_bib66","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/aja.aja_10_19","article-title":"Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer","volume":"21","author":"Xu","year":"2019","journal-title":"Asian J Androl"},{"key":"10.1124\/jpet.121.000898_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tranon.2017.01.011","article-title":"Induction of neuroendocrine differentiation in prostate cancer cells by dovitinib (TKI-258) and its therapeutic implications","volume":"10","author":"Yadav","year":"2017","journal-title":"Transl Oncol"},{"key":"10.1124\/jpet.121.000898_bib68","doi-asserted-by":"crossref","first-page":"45495","DOI":"10.1074\/jbc.M406933200","article-title":"CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000898_bib69","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1038\/ncomms7973","article-title":"Acetylation of MAT II\u03b1 represses tumour cell growth and is decreased in human hepatocellular cancer","volume":"6","author":"Yang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.121.000898_bib70","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1002\/jps.22693","article-title":"Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein","volume":"100","author":"Ye","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.121.000898_bib71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1677\/ERC-07-0061","article-title":"Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells","volume":"14","author":"Yuan","year":"2007","journal-title":"Endocr Relat Cancer"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652400243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652400243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:26:03Z","timestamp":1739971563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652400243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S002235652400243X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000898","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Andrographolide Analogue 3A.1 Synergizes with Taxane Derivatives in Aggressive Metastatic Prostate Cancers by Upregulation of Heat Shock Proteins and Downregulation of MAT2A-Mediated Cell Migration and Invasion","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}